These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10777121)

  • 1. Endocrine effects of the podophyllotoxine derivative drug CPH 82 (Reumacon) in patients with rheumatoid arthritis.
    Carlström K; Hedin PJ; Jönsson L; Lerndal T; Lien J; Weitoft T; Axelson M
    Scand J Rheumatol; 2000; 29(2):89-94. PubMed ID: 10777121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difference in pharmacological activity between CPH 82 and podophyllotoxin.
    Rosén B
    Scand J Rheumatol; 1998; 27(2):159. PubMed ID: 9572647
    [No Abstract]   [Full Text] [Related]  

  • 3. CPH 82 (Reumacon) in refractory inflammatory arthritis.
    Gudmundsdóttir ES; Jónsson H
    Scand J Rheumatol; 2000; 29(5):323-5. PubMed ID: 11093600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference with the cortisol axis by the microtubule antagonist, CPH82.
    Dahlqvist SR; Olsson T
    Br J Rheumatol; 1993 Sep; 32(9):804-6. PubMed ID: 8396491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid-like anti-inflammatory versus immunosuppressive effects of CPH 82 as a single drug therapy of moderately active rheumatoid arthritis patients.
    Masi AT; Chatterton RT
    Scand J Rheumatol; 2000; 29(2):85-8. PubMed ID: 10777120
    [No Abstract]   [Full Text] [Related]  

  • 7. CPH 82.
    BioDrugs; 2003; 17(5):373-4. PubMed ID: 14498767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
    Straub RH; Paimela L; Peltomaa R; Schölmerich J; Leirisalo-Repo M
    Arthritis Rheum; 2002 Mar; 46(3):654-62. PubMed ID: 11920401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPH-82 (Reumacon) versus auranofin (Ridaura): a 36-week study of their respective onset of action rates in RA.
    Bjørneboe O; Moen F; Nygaard H; Haavik TK; Svensson B
    Scand J Rheumatol; 1998; 27(1):26-31. PubMed ID: 9506874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of naproxen and sulphasalazine or methotrexate on hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis.
    Eijsbouts AM; Kempers MJ; van den Hoogen FH; Laan RF; Hermus AR; Ross HA; Sweep FC; van de Putte LB
    Clin Exp Rheumatol; 2011; 29(1):35-42. PubMed ID: 21345290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis.
    Lerndal T; Svensson B
    Rheumatology (Oxford); 2000 Mar; 39(3):316-20. PubMed ID: 10788542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Straub RH; Härle P; Yamana S; Matsuda T; Takasugi K; Kishimoto T; Nishimoto N
    Arthritis Rheum; 2006 Jun; 54(6):1778-85. PubMed ID: 16729287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of growth hormone replacement therapy on adrenal androgen secretion in adult onset hypopituitarism.
    Isidori AM; Kaltsas GA; Perry L; Burrin JM; Besser GM; Monson JP
    Clin Endocrinol (Oxf); 2003 May; 58(5):601-11. PubMed ID: 12699442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased cortisol relative to adrenocorticotropic hormone predicts improvement during anti-tumor necrosis factor therapy in rheumatoid arthritis.
    Straub RH; Pongratz G; Cutolo M; Wijbrandts CA; Baeten D; Fleck M; Atzeni F; Grunke M; Kalden JR; Schölmerich J; Lorenz HM; Tak PP; Sarzi-Puttini P
    Arthritis Rheum; 2008 Apr; 58(4):976-84. PubMed ID: 18383357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testicular and adrenocortical function in healthy men and in men with benign prostatic hyperplasia.
    Stege R; Carlström K
    J Steroid Biochem Mol Biol; 1992 May; 42(3-4):357-62. PubMed ID: 1376613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased DHEAS levels in patients with rheumatoid arthritis after treatment with tumor necrosis factor antagonists: evidence for improved adrenal function.
    Ernestam S; Hafström I; Werner S; Carlström K; Tengstrand B
    J Rheumatol; 2007 Jul; 34(7):1451-8. PubMed ID: 17477470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis.
    Crofford LJ; Kalogeras KT; Mastorakos G; Magiakou MA; Wells J; Kanik KS; Gold PW; Chrousos GP; Wilder RL
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1279-83. PubMed ID: 9100607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of ACTH response to insulin tolerance test in female patients with rheumatoid arthritis due to tumor necrosis factor inhibition.
    Daza L; Martin-Jimenez R; De la Torre PX; Hernández E; Murillo B
    Eur J Endocrinol; 2007 Jul; 157(1):47-51. PubMed ID: 17609401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honokiol possesses potential anti-inflammatory effects on rheumatoid arthritis and GM-CSF can be a target for its treatment.
    Wang XD; Wang YL; Gao WF
    Int J Clin Exp Pathol; 2015; 8(7):7929-36. PubMed ID: 26339358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CPH82 in rheumatoid arthritis. Accumulation of bone marrow cells in mitosis and clinical response.
    Rantapää-Dahlqvist S; Löfvenbert E; Norberg B
    Clin Rheumatol; 1993 Dec; 12(4):541-2. PubMed ID: 8124923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.